To Investigate the Role of Lung Microbiota and Pulmonary Metabolites Changes after Therapeutic Intervetion and the Associated Outcomes in Chronic Obstructive Pulmonary Disease (Copd) (I) = 慢性阻塞性肺病在藥物治療後其肺微生物菌叢及代謝物改變的角色和相關預後 (I)

Project title

慢性阻塞性肺病在藥物治療後其肺微生物菌叢及代謝物改變的角色和相關預後 (I)

Internal ID

MOST107-2314-B002-235-MY3

Principal Investigator

Start Date

August 1, 2018

End Date

July 31, 2019

Investigators

Organizations

Internal Medicine

Partner Organizations

National Science and Technology Council